Parnax Lab Limited

Web: naxparlab.com NSE: PARNAXLAB BSE: 506128 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

135 1(0%)

Near 52W High of 145

Volume

Open

176

High

185

Low

176

136

VWAP

52 Week High

145

52 Week Low

Viand Research Rating

Quality Score

1/100

Growth Score

35/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

155

No. of Shares

1.15

P/E

82.45

P/B

9.67

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.73

ROCE

Profit Growth

Listing Date

Promoter Holding

72.3%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(0.01) 72.30%	(4.71) 72.30%	(0.01) 67.58%	(5.01) 67.58%	(0.01) 62.59%
Public	27.71%	27.71%	27.70%	27.71%	27.70%	27.70%	27.71%	27.71%	27.70%	27.70%	27.70%	27.69%	27.69%	27.70%	27.71%	27.71%	32.42%	32.42%	37.41%
No. of Shareholders	3,572	3,721	3,900	4,111	4,317	4,440	4,521	4,173	4,406	4,496	3,536	3,543	3,221	3,060	3,070	3,096	2,605	2,403	2,259

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	56.8	69.63	62.94	62.6	53.38	49.04	40.22	48.36	50.12	46.37	50.99	42.61	48.74	40.91	46.82	43.14	36.74	47.91	50.68	35.75
Sales Growth % (YoY)	6.4%	42%	56.5%	29.4%	6.5%	5.8%	-21.1%	13.5%	2.8%	13.4%	8.9%	-1.2%	32.7%	-14.6%	-8%	20.7%	28.1%	133.9%	104.1%	33.6%
Sales Growth % (QoQ)	-18.4%	10.6%	0.5%	17.3%	8.8%	21.9%	-16.8%	-3.5%	8.1%	-9.1%	19.7%	-12.6%	19.1%	-12.6%	8.5%	17.4%	-23.3%	-5.5%	41.8%	-
Expenses	52.49	64.75	56.09	54.52	45.94	42.41	35.95	41.12	41.5	40.58	45.02	37.32	42.24	36.18	39.44	37.58	31.43	40.9	43.57	30.2
Operating Profit	4.31	4.88	6.85	8.08	7.44	6.63	4.27	7.24	8.62	5.79	5.97	5.29	6.5	4.73	7.38	5.56	5.31	7.01	7.11	5.55
OPM %	7.59	7.01	10.88	12.91	13.94	13.52	10.62	14.97	17.2	12.49	11.71	12.41	13.34	11.56	15.76	12.89	14.45	14.63	14.03	15.52
Other Income	0.15	1.76	-0.17	0.63	0.18	0.43	0.19	0.95	0.11	0.25	0.1	0.22	0.24	0.27	0.08	0.3	0.12	0.21	0.02	0.07
Interest	1.64	1.61	1.47	1.4	1.22	1.28	1.23	1.38	1.5	1.41	1.35	1.43	1.16	1.18	1.3	1.2	1.26	1.37	1.25	1.44
Depreciation	2.22	2.04	1.96	2.1	1.94	1.83	1.79	1.94	1.83	1.84	1.78	1.74	1.6	1.59	1.74	1.55	1.66	2	1.31	1.3
Profit before tax	0.6	2.99	3.25	5.21	4.46	3.95	1.44	4.87	5.4	2.79	2.94	2.34	3.98	2.23	4.42	3.11	2.51	3.85	4.57	2.88
Tax %	28.33	27.09	16.62	30.33	26.46	26.08	16.67	29.77	26.3	19.35	25.85	20.09	16.33	35.43	28.51	32.48	23.11	104.16	0	0
Net Profit	0.43	2.19	2.71	3.62	3.28	2.93	1.21	3.42	3.99	2.24	2.18	1.87	3.33	1.44	3.16	2.1	1.93	-0.15	4.56	2.88
Net Profit Growth % (QoQ)	-80.4%	-19.2%	-25.1%	10.4%	11.9%	142.1%	-64.6%	-14.3%	78.1%	2.8%	16.6%	-43.8%	131.3%	-54.4%	50.5%	8.8%	1386.7%	-103.3%	58.3%	-
Net Profit Growth % (YoY)	-86.9%	-25.3%	124%	5.8%	-17.8%	30.8%	-44.5%	82.9%	19.8%	55.6%	-31%	-11%	72.5%	1060%	-30.7%	-27.1%	-	-	-	-
TTM Net Profit	8.95	11.8	12.54	11.04	10.84	11.55	10.86	11.83	10.28	9.62	8.82	9.8	10.03	8.63	7.04	8.44	9.22	7.29	7.44	0
EPS in Rs	0.37	1.9	2.36	3.16	2.85	2.54	1.05	2.97	3.47	1.95	1.9	1.63	2.89	1.25	2.74	1.83	1.97	-0.15	5.35	3.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	249	188	189	168	163	90	95	109	106	95	71	103	70	58
Sales Growth %	32.4%	-0.5%	12.6%	2.8%	81%	-5.5%	-12.4%	3.1%	11.3%	33.3%	-30.8%	47.1%	21.1%	-39%
Expenses	221	161	165	145	140	80	89	99	95	82	61	91	62	50
Operating Profit	27	27	24	23	23	10	6	10	10	13	10	12	8	7
OPM %	11	14	12	14	14	11	7	9	10	14	14	12	12	13
Other Income	2	1	1	1	0	0	1	2	1	0	1	1	1	1
Interest	6	5	5	5	5	5	5	4	4	5	4	4	4	4
Depreciation	8	7	7	7	6	5	4	4	4	4	3	3	2	2
Profit before tax	16	16	12	12	12	0	-2	5	3	5	3	5	3	3
Tax %	26	26	20	30	33	350	48	28	65	22	28	22	27	35
Net Profit	12	12	10	9	8	0	-3	3	1	4	3	4	2	2
Net Profit Growth %	-	20%	11.1%	12.5%	-	100%	-200%	200%	-75%	33.3%	-25%	100%	-	-
EPS in Rs	10.26	10.03	8.37	7.51	8.4	-0.42	-3.42	3.88	1.23	4.33	2.95	5.01	2.93	2.01
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	8	32	16	21	9	6	9	9	13	16	3	0	0	6
Cash from Investing Activity	-16	-16	-32	-10	-16	-7	-13	-11	-5	-10	-6	-4	-6	-1
Cash from Financing Activity	8	-16	15	-14	12	0	5	1	-7	-5	1	6	6	-3
Net Cash Flow	0	0	-1	-3	4	0	0	-1	1	0	-2	1	0	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	11	11	11	11	11	11	10	8	8	8	8	8	8	8	8	8
Reserves	84	78	72	67	60	51	38	24	24	27	24	23	19	17	12	10
Borrowings	83	69	70	75	81	55	69	59	51	42	37	39	42	41	33	27
Other Liabilities	50	50	37	26	38	28	36	15	23	17	18	15	10	17	29	15
Total Liabilities	228	208	190	180	190	145	153	106	107	95	87	86	79	83	83	60
Fixed Assets	115	113	88	114	89	77	72	60	58	51	44	47	38	36	36	33
CWIP	11	14	29	1	21	2	3	5	3	0	0	0	2	1	1	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1
Other Assets	101	82	72	66	80	66	78	41	46	43	43	38	38	45	46	27
Total Assets	228	208	190	180	190	145	153	106	107	95	87	86	79	83	83	60

Delivery

Delivery Data: PARNAXLAB

#	Date	108 34% 145	Q/T 59	Del 76
1	4-Sep	135	18	94
2	3-Sep	136	107	94
3	2-Sep	137	43	57
4	1-Sep	141	87	68
5	31-Aug	132	75	94
6	28-Aug	128	78	100
7	27-Aug	123	86	98
8	26-Aug	124	27	58
9	25-Aug	130	21	93
10	24-Aug	124	20	86
11	21-Aug	128	11	96
12	20-Aug	122	93	52
13	19-Aug	120	15	100
14	18-Aug	122	32	89
15	17-Aug	120	71	99

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	155c	2L	0.01
03-Sep	155c	1c	0.72
01-Sep	156c	8c	5.43
31-Aug	148c	6c	4.53
27-Aug	142c	2c	1.16
25-Aug	140c	3c	1.91
24-Aug	143c	6c	3.84
21-Aug	149c	8c	5.63
19-Aug	141c	52L	0.37
18-Aug	140c	4c	2.91
17-Aug	136c	0	0

Stock Checklist

Price is above from 52 week high low average: 84%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹12 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	2	0.17%	-0.08%	11.7

Parnax Lab Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements